Shanghai ZJ Bio-Tech Co., Ltd (SHA:688317)

China · Delayed Price · Currency is CNY

20.32

+0.42 (2.11%)

Mar 10, 2026, 1:14 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
In Vitro Diagnostics Industry		178.65M	274.33M					-	-	-
In Vitro Diagnostics Industry Growth		-34.88%	-					-	-	-
Gynecology		-	-					-	-	59.58M
Gynecology Growth		-	-					-	-	35.74%
Respiratory Tract		-	-					-	-	34.44M
Respiratory Tract Growth		-	-					-	-	16.25%
STD		-	-					-	-	11.67M
STD Growth		-	-					-	-	44.51%
Intestine		-	-					-	-	17.93M
Intestine Growth		-	-					-	-	14.46%
Hepatitis		-	-					-	-	10.76M
Hepatitis Growth		-	-					-	-	-0.76%
Others		-	-					-	-	16.19M
Others Growth		-	-					-	-	21.16%
Total		178.65M	274.33M					-	-	150.56M
Total Growth		-34.88%	-					-	-	23.96%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China		166.18M	-					224.35M	192.71M	145.72M
China Growth		-	-					16.42%	32.25%	26.50%
Overseas		9.34M	-					-	-	4.85M
Overseas Growth		-	-					-	-	-22.68%
Total		175.52M	-					224.35M	192.71M	150.56M
Total Growth		-	-					16.42%	27.99%	23.96%

Source: S&P Global Market Intelligence.